Patient Treatment Date/time: Diagnosis: Treatment Regimen:
|
|
- Derek Jones
- 5 years ago
- Views:
Transcription
1 Name: Address: DOB: HCRN: Consultant: Ward: Assessment: Pre Systematic Anti Cancer Therapy (SACT) Continuation *This assessment is for patients on multiday regimens Patient Treatment Date/time: Diagnosis: Treatment Regimen: Cycle number: Cycle day: Vital Signs/Early Warning Score completed NA Have all necessary bloods been completed? FBC U&E Liver profile Bone profile Coagulation Screen Iron Studies TFTs CRP Other Details: Tumour markers Details: Blood results reviewed and satisfactory to proceed with treatment? Details: Peripheral Intravenous Cannulation (PIVC) Record How many attempts to successfully cannulate: Time/date Size of PIVC Vein 1 Blood return VIPs score 1 Patient tolerance of procedure achieved 2 Initial/NMBI pin 1 See appendix 1 and indicate if the right or left arm used 2 If no or poor blood return achieved, please document action in nursing note
2 Patient Name DOB HCrN Central Venous Access Device (CVAD) Record PICC Port Hickman Vascath Other Details: Time/Date Lumen Blood return Lumens flushed and Catheter external Description of exit site colour achieved? 3 patent? 3 length (if applicable) Red Blue Yellow Brown Red Blue Yellow Brown Red Blue Yellow Brown initial/nmbi Pin Pre treatment checks CTCAE Version 4 4 Grade CTCAE Version 4 Grade Chest pain Weight loss Infection Diarrhoea Bleeding Constipation Dyspnoea Urinary disorder Confusion/cognitive disturbance Fatigue Pain Peripheral neuropathy -sensory Mood alteration Peripheral neuropathy -motor Mucositis/stomatitis Bruising Nausea Rash Vomiting Occular/Eye problems Anorexia Palmer/Planter Syndrome Other ECOG Status 5 SACT Administration Blood return present prior to commencing and throughout treatment? SACT fully infused without any adverse events If ambulatory SACT pump attached correctly? NA If ambulatory SACT pump attached, is clamp open? NA Assessment completed by: NMBI pin: Please document additional details in notes section if required 3 If No, document further actions in nurses notes section 4 See appendix 2 for CTCAE version 4 5 See appendix 3 for ECOG score
3 Patient Name DOB HCrN Does the patient require admission? Has PIVC been flushed & removed? Any PIVC complications? CVAD flushed as per hospital policy? Any CVAD complications? Has Huber needle been removed? (if applicable) Discharge Location: NA Time PIVC removed: Comments: NA Comments: NA Comments: If 5fu pump attached on discharge, has disconnection been arranged? Has spill kit been given to patient (If applicable) Safe handling and disposal of cytotoxic drug information leaflet given? Date given for CVAD flush and dressing if not for treatment before next due? NA Give details of disconnection: Time: Date: Location: Day ward CIT NA Yes No NA Is the Patient for any supportive medications at home? Did the patient receive a prescription? Details: NA Give details of flush/dressing Time: Date: Location: Day ward CIT PHN If the patient is for G-CSF, is administration arranged? NA Details: MDT referrals/community supports arranged this visit Is patient for follow up/review appointment? NA Has the appointment been arranged? NA Details: Have blood requests for next appointment been given to patient? NA Details: Next day ward appointment date: Next appointment time: Reason: Assessment completed by NMBI pin
4 Patient Name DOB HCrN Time Notes Sign/NMBI Signature Bank Name Signature Initials Role NMBI Pin
5 Appendix 1: Visual Infusion Score (VIPS) Visual Infusion Phlebitis Score (VIPS) Condition of site Score IV site appears healthy 0 One of the following is evident: 1 Slight pain near IV site Slight redness near IV site Two of the following are 2 evident: Pain at IV site Erythema Swelling Appendix 2: Common Terminology Criteria for Adverse Events- CTCAE Version 4 Grades Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Chest pain Location? When did it start? Mild Pain pain; limiting instrumental Pain at rest; Infection Has the patient taken their own temp? Any chills, shivering, shaking episodes? Any local signs? Are they neutropenic? Dyspnoea It is a new symptom? Is it worsening? Any chest pain and for how long? *consider SVCO, anemia, treatment related Confusion/cogniti ve disturbance Is this symptom new? How long have they had these symptoms? Is it getting worse? Any s to medications? Pain Is it a new symptom? How long? Is the pain constant? or no or no or no Asymptomatic or mild symptoms not requiring intervention New onset shortness of breath with moderate exertion Mild disorientation not interfering with s. Slight decrease in level of alertness Mild pain: not interfering with function Localised. Localised intervention indicated Shortness of breath with minimal exertion; limiting instrumental cognitive disability and/or disorientation limiting s pain: pain or analgesia not activities of daily living Intravenous antibiotics indicated Shortness of breath at rest; Severe cognitive disability and/or severe confusion; severely limiting s. Altered level of consciousness Severe pain: Pain or analgesia s Death consequences, loss of consciousness Disabling
6 Grades Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Mood alteration How long have they felt this way? What help them feel better? What supports are in place? Mild mood alteration, not function mood alteration, not s Severe mood alteration s Mucositis/Stomati tis Are there mouth ulcers? Evidence of infection? Able to eat and drink? Asymptomatic or mild symptoms pain not interfering with oral intake Severe pain, oral intake Suicidal ideation Danger to self or others Requires parentrenal/entren al support Nausea What is their oral intake like? Are they taking antiemetic? Vomiting How many days/episodes? Are they constipated or have diarhorea? Loss of appetite without alteration in eating habits 1-2 episodes in 24 hours Oral intake decrease without significant weight loss or dehydration 3-5 episodes in 24 hours Inadequate oral caloric and fluid intake >6 episodes in 24 hours consequences Anorexia What is appetite like? Has it recently d? Weight loss Are they trying to lose weight? Diarrhoea *Consider infection Constipation How many days since LBM? What s their baseline? Any nausea, vomiting or abdominal pain? Urinary frequency Fatigue Any other associated symptoms? or no Loss of appetite without to eating habits 5-10% less than baseline Increase of <4 stools per day over baseline. Mild increase in ostomy output Occasional or intermittent symptoms, occasional use of laxatives Nocturia or increase x 2 times function Mild: Increase in baseline fatigue, but not effecting daily activities Oral intake altered without significant weight loss or malnutrition 10-20% less than baseline Increase of 4-6 stools per day over baseline. increase in ostomy output Persistent symptoms with regular use of laxatives/ene mas and limited s (activities of daily living) Increase>2 times x <hourly : Decrease in performance and difficulties with s and Oral intake altered in association with significant weight loss/malnutrition >20% less than baseline Increase of >7 stools per day over baseline Severe increase in ostomy output Constipation >1 hourly urgencycatheter indicated Severe Significant decrease in performance and interferes with ALDs complications such as collapse consequences Obstruction/Life threatening consequences Disabling
7 Grades Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Peripheral Neuropathy When did it start? Is it continuous? Is it getting worse or affecting mobility or function? Any constipation or urinary incontinence? Asymptomatic parenthesis/tingl ing persistent. Not interfering with s Sensory alteration, Interferes with not s Sensory alteration, Interferes with s Disabling Permanent sensory loss *consider spinal cord compression Bruising Localized or in a dependent area Rash Macules/papule Is it localized or s covering < generalized? 10% BSA with How long has it or without been there? symptoms (e.g., Signs of infection? pruritus, Is there any itch? burning, tightness) Nail Changes When did it start? How long has it been there? or no Discolored, ridging, pitting Generalized Macules/papul es covering 10-30% BSA with or without symptoms (e.g., pruritus, burning, tightness); limiting instrumental Partial or complete nail loss Macules/papule s covering >30% BSA with or without associated symptoms; Interferes with s Palmer/planter syndrome Mild numbness, tingling swelling of hands and feet with or without pain or redness Painful redness and/or swelling of the hands and/or feet Moist desquamation, ulceration and severe pain Appendix 3: ECOG Status ECOG Status ECOG score 0 ECOG score 1 ECOG score 2 ECOG score 3 ECOG score 4 Fully active, able to carry on all predisease performance without restriction Capable of only limited self care, confined to bed or chair more than 50% of waking Completely disabled Cannot carry on any self- care. Totally confined to bed or chair hours Restricted in physically strenuous activity but ambulatory and able to carry out work of light or sedentary nature, e.g. light house work, office work Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% or waking hours Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol. 1982;5:
PREOPERATIVE ANAEMIA PATHWAY
PREOPERATIVE ANAEMIA PATHWAY Surname: Unit No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: GP Name: GP Practice: Planned Operation: Postcode: Mobile
More informationT: N: M: EORTC SYSTEMIC THERAPY CHECKLIST. Protocol number: SeqID. Copyright EORTC August 2007 COMPARATIVE PERFORMANCE STATUS TABLE
EORTC SYSTEMIC THERAPY CHECKLIST Copyright EORTC August 2007 (Stick the patient s identification label here) Protocol number: SeqID. T: N: M: WHO / ECOG 0 Normal activity. 1 Symptoms but ambulatory. 2
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced
More informationFor the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum
For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using and Platinum HN = Head and Neck (Tumour group) AV = Advanced FU = P = Platinum (Cisplatin or Carboplatin)
More informationFor the Patient: Rituximab injection Other names: RITUXAN
For the Patient: Rituximab injection Other names: RITUXAN Rituximab (ri tux' i mab) is a drug that is used to treat some types of cancer. It is a monoclonal antibody, a type of protein designed to target
More informationFor the Patient: USMAVFIPI
For the Patient: USMAVFIPI Other Names: First-Line Treatment of Unresectable or Metastatic Melanoma Using Ipilimumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced F =
More informationSCALES SCALES SCALES. Performance Scales WHAT SHOULD THE RAINBOW FISH DO WITH ALL OF THESE SCALES?? KPS FAST ECOG PPS NYHA MRI ALSFRS
SCALES SCALES SCALES WHAT SHOULD THE RAINBOW FISH DO WITH ALL OF THESE SCALES?? Karen L. Cross, MD, FAAHPM Performance Scales KPS FAST ECOG PPS NYHA MRI ALSFRS PPS = 30, 40, or 50 ECOG = 2, 3, or 4 NYHA
More informationFor the Patient: Mitoxantrone Other names:
For the Patient: Mitoxantrone Other names: Mitoxantrone (mite-oh-zan-trone) is a drug that is used to treat many types of cancer. It is a blue liquid that is injected into a vein. Tell your doctor if you
More informationFor the Patient: Amsacrine Other names: AMSA PD
For the Patient: Amsacrine Other names: AMSA PD Amsacrine (AM-sa-krin) is a drug that is used to treat some types of cancer. It is a clear orange-red liquid that is injected into a vein. Tell your doctor
More informationEloxatin Oxaliplatin concentrated solution for injection
Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common
More informationFor the Patient: Paclitaxel Other names: TAXOL
For the Patient: Paclitaxel Other names: TAXOL Paclitaxel (pak'' li tax' el) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if
More informationEdinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF)
Introduction This booklet has been designed to help you and your family understand more about the chemotherapy that you are about to have as treatment for your cancer. If you need more information or have
More informationNURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)
NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions.
More informationManagement of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital
Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms
More informationPatient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?
17.6 FDA-Approved Patient Labeling Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) for Injection, for intravenous infusion only Read the Patient Information that comes with IXEMPRA
More informationDocetaxel (Taxotere )
Page 1 of 5 Docetaxel (Taxotere ) About This Drug Docetaxel is used to treat cancer. It is given in the vein (IV). Possible Side Effects Bone marrow depression. This is a decrease in the number of white
More informationFor the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.
For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V. Cyclosporine (sye kloe spor een) is a drug that may be used to treat certain types of cancer. It may also be used to suppress your immune
More informationFor the Patient: Bendamustine Other names: TREANDA
For the Patient: Bendamustine Other names: TREANDA Bendamustine (ben'' da mus' teen) is a drug that is used to treat some types of cancer (lymphoma). It is a clear liquid that is injected into a vein.
More information2. Have your symptoms affected your ability to carry out your daily activities? YES NO
QUESTIONNAIRE Page 1 of 5 Date: Referring MD (Name, Address, Phone Number): Primary Care Physician (Name and Address, Phone Number): Reason for visit: 1. How long have you had symptoms? Describe your symptoms?
More informationDocetaxel (Taxotere) with GCSF
Docetaxel (Taxotere) with GCSF Docetaxel (Taxotere) with GCSF for hormone This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy
More informationVIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours
VIDE VIDE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may
More informationFor the Patient: GOOVDDCAT
For the Patient: GOOVDDCAT Other Names: Primary Treatment of Advanced Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer Using Carboplatin and Paclitaxel GO = Gynecologic Oncology (tumor
More informationYOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)
YOUR GUIDE TO TECENTRIQ (atezolizumab) For previouslytreated advanced non-small cell lung cancer (NSCLC) ABOUT THIS BOOKLET This booklet is for people with advanced non-small cell lung cancer (NSCLC) who
More informationFor the Patient: GOOVCATM
For the Patient: GOOVCATM Other Names: Treatment of No Visible Residual (Moderate- High Risk) Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer Using Carboplatin and Paclitaxel
More informationFor the Patient: GOOVCATR
For the Patient: GOOVCATR Other Names: Second Line Treatment of Invasive Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Relapsing After Primary Treatment Using Carboplatin and Paclitaxel GO Gynecologic
More informationABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.
For the Patient: HNNAVGEM Treatment of Recurrent or Metastatic Nasopharyngeal Cancer with Gemcitabine HN = Head and Neck N = Nasopharyngeal AV = Advanced GEM = Gemcitabine ABOUT THIS MEDICATION What is
More informationABOUT THIS MEDICATION
For the Patient: HNAVPC Other Names:Treatment of Recurrent or Metastatic Squamous Cell Cancer with Paclitaxel and Cisplatin or Carboplatin HN = Head and Neck AV = AdVanced P = Paclitaxel C = Cisplatin
More informationMyeloma Haematology and Transplant Unit
BCD Myeloma Haematology and Transplant Unit BCD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
More informationDiscussing TECENTRIQ (atezolizumab) with your healthcare team
Discussing TECENTRIQ (atezolizumab) with your healthcare team What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: a type of lung cancer called non-small cell lung cancer (NSCLC). TECENTRIQ
More informationSpinal Anaesthesia and Analgesia. Patient information Leaflet
Spinal Anaesthesia and Analgesia Patient information Leaflet February 2018 Introduction For many operations, patients receive a general anaesthetic and remain asleep during the operation. A spinal anaesthetic
More informationFor the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine
For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine GI = GastroIntesntinal P = Pancreatic AJ = Adjuvant GEM = Gemcitabine ABOUT THIS MEDIATION What is this
More informationFor the Patient: Trastuzumab emtansine Other names: KADCYLA
For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear
More informationFor the Patient: Fludarabine injection Other names: FLUDARA
For the Patient: Fludarabine injection Other names: FLUDARA Fludarabine (floo-dare-a-been) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell
More informationFor the Patient: Eribulin Other names: HALAVEN
For the Patient: Eribulin Other names: HALAVEN Eribulin (er'' i bue' lin) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you
More informationFor the Patient: USMAVPEM
For the Patient: USMAVPEM Other Names: Treatment of Unresectable or Metastatic Melanoma Using Pembrolizumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced PEM = Pembrolizumab
More informationFor the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.
For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. GI = GastroIntestinal P = Pancreas GEM = Gemcitabine ABOUT THIS MEDIATION What is this drug used for? Gemcitabine
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr Cytarabine Injection 100 mg/ml This leaflet is part III of a three-part "Product Monograph" published when Cytarabine Injection was approved for sale in Canada and is
More informationFor the Patient: ULUAVPMTN
ABOUT THIS MEDICATION For the Patient: ULUAVPMTN Other Names: Maintenance Therapy of Advanced n-small Cell Lung Cancer (NSCLC) with Pemetrexed U = Undesignated (requires special approval) LU = LUng AV
More informationNivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions
Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number
More informationFor the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab
For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab GI = GastroIntestinal AV = Advanced PANI = Panitumumab ABOUT THIS MEDIATION
More informationProf A Pourazar Immunohematologist
Prof A Pourazar Immunohematologist What is plasma? Plasma is part of blood. It is the liquid that supports the circulation of red blood cells, white blood cells and platelets. Plasma is mainly water and
More informationFor the Patient: LUAJPC
ABOUT THIS MEDICATION For the Patient: LUAJPC Other Names: Treatment of Resected n-small Cell Lung Cancer with Carboplatin and Paclitaxel LU = LUng AJ = AdJuvant PC = Paclitaxel, Carboplatin What are these
More informationVDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.
VDC IE VDC IE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others
More informationCisplatin and Capecitabine
Cisplatin and Capecitabine Cisplatin and Capecitabine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk
More informationFor the Patient: Ponatinib Other names: ICLUSIG
For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you
More informationThe treatment is given every 3 weeks for 6 to 8 cycles.
R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it
More informationFor the Patient: GUBEP
For the Patient: GUBEP Other Names: Treatment with Bleomycin, Etoposide, Cisplatin for Germ Cell Cancers. GU = GenitoUrinary (tumor group) B = Bleomycin E = Etoposide P = Platin (Cisplatin) ABOUT THIS
More informationBreast Pathway Group Docetaxel in Advanced Breast Cancer
Breast Pathway Group Docetaxel in Advanced Breast Cancer Indication: First-line palliative treatment, with or without trastuzumab, for advanced breast cancer in patients for whom an anthracycline is not
More informationObinutuzumab (lymphoma) Obinutuzumab (lymphoma)
Obinutuzumab (lymphoma) Obinutuzumab (lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of this treatment vary: for some people, this immune therapy may reduce
More informationWhat are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.
For the Patient: HNNAVPC Other Names: Treatment of Recurrent and/or Metastatic Nasopharyngeal Cancer with Paclitaxel and Carboplatin HN = Head and Neck N = Nasopharyngeal AV = AdVanced P = Paclitaxel C
More informationUnderstanding your HICKMAN CATHETER
Understanding your HICKMAN CATHETER Patient Information What is the purpose of this information sheet? This information sheet has been written by patients, members of the public and health professionals.
More informationSupplementary Online Content
Supplementary Online Content Basch E, Dueck AC, Rogak LJ, et al. Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials. JAMA Oncol. Published online
More informationNew Patient History. Name: DOB: Sex: Date: If yes, give the name of the physician who did your evaluation or ordered your tests:
New Patient History Name: DOB: Sex: Date: Chief Complaint: 1. Give a brief description of the problem you are seeking treatment for today: 2. Have you been evaluated for this problem or had any tests for
More informationGCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes
GCVP GCVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may
More information5 Fluorouracil. Other Names: Adrucil. About This Drug. Possible Side Effects. Fluorouracil is used to treat cancer.it is given in the vein (IV).
5 Fluorouracil Other Names: Adrucil About This Drug Fluorouracil is used to treat cancer.it is given in the vein (IV). Possible Side Effects Hair loss. Hair loss is often temporary, although with certain
More informationNivolumab. Nivolumab
Nivolumab Nivolumab This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people immunotherapy may reduce the risk of the cancer coming back, for
More informationDexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.
Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased
More informationLung Pathway Group Docetaxel & Carboplatin in Non- Small Cell Lung Cancer (NSCLC)
Lung Pathway Group Docetaxel & Carboplatin in Non- Small Cell Lung Cancer (NSCLC) Indication: First line palliative therapy for previously untreated Stage IIIB or IV NSCLC patients Regimen details: Docetaxel
More informationAmarillo Surgical Group Doctor: Date:
Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:
More informationMaternity Services Intravenous iron therapy Information for women
Maternity Services Intravenous iron therapy Information for women Please read this leaflet carefully. It has been written to give you information about your treatment with intravenous iron therapy. What
More informationFor the Patient: USMAVNIV
For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab
More informationPain relief after major surgery
Page 1 of 6 Pain relief after major surgery Introduction The aim of this leaflet is to tell you about the main pain relief options available after major surgery. You will probably only need this for the
More informationABOUT THIS MEDICATION
For the Patient: UHNOTVAN Other Names: Therapy for Medullary Thyroid Cancer using Vandetanib HN = Head and Neck (tumour group) OT = Other (includes Thyroid) VAN = VANdetanib ABOUT THIS MEDICATION What
More informationGemcitabine and Cisplatin (urology)
Gemcitabine and Cisplatin Gemcitabine and Cisplatin (urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce
More informationFor the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide
For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide Other names: BRLATWAC BR Breast LA Locally Advanced T A C Paclitaxel
More informationPain Management Questionnaire
In order to make the most of your visit, we require this form to be completed to the best of your ability and sent to the Pain Management Clinic a copy should be shared with your Primary Care Provider
More informationPREOPERATIVE ANAEMIA PATHWAY
PREOPERATIVE ANAEMIA PATHWAY Surname: Patient ID No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: Next of Kin: Name GP Name: GP Practice: Planned Operation:
More informationFor the Patient: ULUAVPMB
For the Patient: ULUAVPMB Other Names: Treatment of Advanced Non-Small Cell Lung Cancer Using Pembrolizumab U = Undesignated (requires special approval) LU = LUng AV = AdVanced PMB = PeMBrolizumab ABOUT
More informationBreast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer
Breast Pathway Group TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer Indication: Neoadjuvant or adjuvant treatment for patients in whom anthracyclines are contraindicated or inappropriate Regimen
More informationFor the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine
For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine LU = LUng AJ = AdJuvant NP = Navelbine (vinorelbine), cisplatin ABOUT THIS
More informationFor the Patient: LUAVPP
ABOUT THIS MEDICATION For the Patient: LUAVPP Other Names: Treatment of Advanced n-small Cell Lung Cancer with Cisplatin and Pemetrexed LU = LUng AV = AdVanced PP = CisPlatin, Pemetrexed What are these
More informationFor the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin
For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin GI = GastroIntestinal AV = Advanced PG = Cisplatin,
More informationMyeloma Haematology and Transplant Unit CTD1
CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of
More informationYOUR OPERATION EXPLAINED
RIGHT HEMICOLECTOMY This leaflet is produced by the Department of Colorectal Surgery at Beaumont Hospital supported by an unrestricted grant to better Beaumont from the Beaumont Hospital Cancer Research
More informationFor the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)
For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin) Other names: UBRAJTTW U Undesignated BR Breast AJ Adjuvant T Trastuzumab (HERCEPTIN ) TW Paclitaxel
More informationNilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.
For the Patient: Other names: TASIGNA (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Blood tests may be taken regularly during treatment.
More informationPaclitaxel (Taxol) and carboplatin
Paclitaxel (Taxol) and carboplatin Paclitaxel (Taxol) and carboplatin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may
More informationFor the Patient: Olaparib tablets Other names: LYNPARZA
For the Patient: Olaparib tablets Other names: LYNPARZA Olaparib (oh lap' a rib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have
More informationHaematology. The other 2 drugs, folinic acid and GCSF, help to reduce the side effects of the treatment.
Haematology CODOX-M Chemotherapy This information is about CODOX-M chemotherapy, which is a treatment for Burkitts Lymphoma. Lymphoma is a cancer of the lymphatic system - a network of glands in the body
More informationHow is this regimen given? Are there other medications I will receive with this regimen? What side effects can occur with this regimen?
Weekly Paclitaxel Weekly paclitaxel (Taxol ) is a chemotherapy regimen or treatment plan that your doctor prescribed for the treatment of your cancer. How is this regimen given? Paclitaxel (Taxol ) is
More informationMedical History Form
Medical History Form Name: ; Birth date: / / ; Date: / / Person filling out form: ; Relationship: Thank you for taking the time to fill out this valuable information. This allows us to provide the best
More informationFor the Patient: ACTW Other names: BRAJACTW
For the Patient: ACTW Other names: BRAJACTW A Doxorubicin (ADRIAMYCIN ) C Cyclophosphamide T Paclitaxel (TAXOL ) weekly Uses: BRAJACTW is a drug treatment given after breast cancer surgery (called adjuvant
More informationDiscussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor
Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder
More informationFor the Patient: LUAVPG
For the Patient: LUAVPG Other Names: Treatment of Advanced n-small Cell Lung Cancer with Cisplatin and Gemcitabine LU = LUng AV = AdVanced PG = cisplatin, Gemcitabine ABOUT THIS MEDICATION What are these
More informationFor the Patient: ACD
For the Patient: ACD Other names: BRLAACD A Doxorubicin C Cyclophosphamide D Docetaxel (TAXOTERE ) Uses: BRLAACD is a drug treatment given usually before (called neoadjuvant chemotherapy), but occasionally
More informationWhat is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?
1 of 5 6/10/2016 3:46 PM Generic Name: bortezomib (bor TEZ oh mib) Brand Name: Velcade What is bortezomib? Bortezomib interferes with the growth of some cancer cells and keeps them from spreading in your
More informationSTEP 1: Forms Please complete all the attached forms and bring them with you on the day of your visit.
PATIENT HEALTH HISTORY FORM DIRECTIONS AND VISIT DAY INSTRUCTIONS Prior to your Appointment: STEP 1: Forms Please complete all the attached forms and bring them with you on the day of your visit. STEP
More informationBrentuximab vedotin. Brentuximab vedotin
Brentuximab vedotin Brentuximab vedotin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
More informationABVD. by infusion over 30 minutes. You will have treatment on Day 1 and Day 15 (this is one cycle) for 2, 3 or 6 cycles.
ABVD ABVD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may
More informationPaclitaxel (Taxol) Paclitaxel is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.
Paclitaxel (Taxol) Paclitaxel (Taxol) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
More informationVELCADE Powder for Injection Bortezomib3.5 mg and 1 mg
VELCADE Powder for Injection Bortezomib3.5 mg and 1 mg Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VELCADE Powder for Injection. It does not contain
More informationHD CLINIC MEDICAL HISTORY FORM
HD CLINIC MEDICAL HISTORY FORM Welcome to the HDSA Center of Excellence HD Clinic. Please take a few moments to answer the questions below as best as you can. If you need assistance, a caregiver/companion
More informationINTRAVENOUS IRON THERAPY
INTRAVENOUS IRON THERAPY Information for women Maternity Services Please read this leaflet carefully. It has been written to give you information about your treatment with intravenous iron therapy. WHAT
More informationTransarterial Chemoembolization (TACE)
Transarterial Chemoembolization (TACE) Princess Margaret Know what to expect Read this booklet to learn: What TACE is...1 How TACE works...2 The benefits of TACE...3 The risks and side effects of TACE...3
More informationYour CODOX-M / IVAC treatment. Information for patients Specialised Medicine
Your CODOX-M / IVAC treatment Information for patients Specialised Medicine What is CODOX-M / IVAC? CODOX-M / IVAC is a form of chemotherapy which is used at the Royal Hallamshire Hospital to treat some
More informationABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.
For the Patient: HNAVDOC Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck with docetaxel HN=Head and Neck AV=Advanced DOC=Docetaxel ABOUT THIS MEDICATION What are these drugs
More informationPAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY
PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic
More informationMyeloma Haematology and Transplant Unit MPT
MPT Myeloma Haematology and Transplant Unit MPT This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
More information